Abstract
The rat is a well-established model for hypertension research, in both physiologic and pharmacologic study. Quantitative trait loci (QTL) for blood pressure and related phenotypes have been described on every rat chromosome; therefore, more simplified models must be generated to identify and study the function of the gene(s) located by QTL analysis. Designer rat strains, such as congenic and consomic strains, which share phenotypic and genotypic characteristics with humans but with a greatly simplified genetic background, would yield a powerful platform for functional studies, especially when combined with microarray technologies. Development of these designer rats would result in better-defined disease models that can be used in physiologic and applied pharmacologic studies to better treat human essential hypertension.
Similar content being viewed by others
References and Recommended Reading
Ward R: Familial aggregation and genetic epidemiology of blood pressure. In Hypertension: Pathophysiology, Diagnosis and Management. Edited by Laragh JH, Brenner BM. New York: Raven Press; 1990:81–100.
Hamet P, Pausova Z, Adarichev V, et al.: Hypertension: genes and environment. J Hypertens 1998, 16:397–418.
Dominiczak A, Negrin DC, Clark JS, et al.: Genes and hypertension: from gene mapping in experimental models to vascular gene transfer strategies. Hypertension 2000, 35:164–172. Good review of current rat resources.
Simon D, Karet FE, Hamdan JM, et al.: Bartter‘s syndrome, hypokalaemic alkalosis with hypercalciuria, is caused by mutations in the Na-K-2Cl cotransporter NKCC2. Nature Genet 1996, 13:183–188.
Simon D, Karet FE, Rodriguez-Soriano J, et al.: Genetic heterogeneity of Bartter‘s syndrome revealed by mutations in the K+ channel, ROMK. Nature Genet 1996, 14:152–156.
Shimkets RA, Warnock DG, Bositis CM, et al.: Liddle‘s syndrome: heritable human hypertension caused by mutations in the B subunit of the epithelial sodium channel. Cell 1994, 79:407–414.
Casari G, Barlassina C, Cusi D, et al.: Association of the alpha-adducin locus with essential hypertension. Hypertension 1995, 25:320–326.
Jeunemaitre X, Soubrier F, Kotelevtsev YV, et al.: Molecular basis of human hypertension: role of angiotensinogen. Cell 1992, 71:169–180.
Jeunemaitre X, Lifton RP, Hunt SC, et al.: Absence of linkage between the angiotensin converting enzyme locus and human essential hypertension. Nature Genet 1992, 1:72–75.
Harrap S, Davidson HR, Conor JM, et al.: The angiotensin I-converting enzyme gene and predisposition to high blood pressure in man. Hypertension 1993, 21:455–460.
Iwai N, Ohmichi N, Hanai K, et al.: Human SA gene locus as a candidate locus for essential hypertension. Hypertension 1994, 23:375–380.
Kato N, Sugiyama T, Tabika T, et al.: Lack of association between alpha-adducin locus and essential hypertension in the Japanese population. Hypertension 1998, 31:730–733.
Brand E, Chatelain N, Keavney B, et al.: Evaluation of the angiotensinogen locus in human essential hypertension. Hypertension 1998, 31:735–739.
Niu T, Xu X, Rogos J, et al.: Angiotensinogen gene and hypertension in Chinese. J Clin Invest 1998, 101:188–194.
Julier C, Delepine M, Keavney B, et al.: Genetic susceptibility for human familial essential hypertension in a region of homology with blood pressure linkage on rat chromosome 10. Human Molec Genet 1997, 6:2077–2085.
Krushkal J, Xiong M, Ferrell R, et al.: Linkage and association of adrenergic and dopamine receptor genes in the distal portion of the long arm of chromosome 5 with systolic blood pressure variation. Human Molec Genet 1998, 7:1379–1383.
Mansfield TA, Simon DB, Farfel Z, et al.: Multilocus linkage of familial hyperkalaemia and hypertension, pseudohypoaldosteronism type II, to chromosomes 1q31-42 and 17p11-q21. Nature Genet 1997, 16:202–205.
Rapp J: Genetic analysis of inherited hypertension in the rat. Physiol Rev 2000, 80:135–172. Very thorough review of the rat models for hypertension as well as basic background information on linkage.
Stoll M, Kwitek-Black AE, Cowley AW Jr, et al.: New target regions for human hypertension via comparative genomics. Genome Res 2000, 10:473–482.
Snell G: Methods for study of histocompatibility genes. J Genet 1948, 49:87–108.
Markel PS, Ebeling C, Carlson GA, et al.: Theoretical and empirical issues for marker-assisted breeding of congenic mouse strains. Nature Genet 1997, 17:292–297. This paper describes the speed congenic approach.
Wakeland E, Morel L, Achey K, et al.: Speed congenics: a classic technique in the fast lane (relatively speaking). Immunol Today 1997, 18:472–477. This paper also describes the speed congenic approach.
Zhang Q, Dene H, Jacob H, et al.: Interval mapping and congenic strains for a blood pressure QTL on rat chromosome 13. Mammalian Genome 1997, 9:636–641.
St Lezin E, Griffin KA, Picken M, et al.: Genetic isoloation of a chromosome 1 region affecting susceptibility to hypertension-induced renal damage in the spontaneously hypertensive rat. Hypertension 1999, 34:187–191.
Jiang J, Stec DE, Drummond H, et al.: Transfer of a saltresistant renin allele raises blood pressure in Dahl saltsensitive rats. Hypertension 1997, 29:619–627.
Cowley A, Roman RR, Kaldunski ML, et al.: Transfer of brown Norway rat chromosome 13 into Dahl S genomic background confers protection from high salt diet [abstract P132]. Hypertension 2000, 36:717.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Kwitek-Black, A.E., Jacob, H.J. The use of designer rats in the genetic dissection of hypertension. Current Science Inc 3, 12–18 (2001). https://doi.org/10.1007/s11906-001-0072-0
Issue Date:
DOI: https://doi.org/10.1007/s11906-001-0072-0